Within the mammoth defense bill,…
Within the mammoth defense bill, the Biosecure Act has the [...]
Within the mammoth defense bill, the Biosecure Act has the [...]
“Following the withdrawal of Ocaliva from the U.S. market, we [...]
Plus, the subway stop that’s also a museum.
Bristol Myers Squibb has become the latest Big Pharma to [...]
Los científicos no están del todo seguros de qué causa [...]
University of California spinout Addition Therapeutics has uncloaked, revealing “breakthrough” [...]
Tuesday, the U.S. regulator greenlit GSK’s depemokimab, an ultra-long-acting biologic, [...]
Nektar Therapeutics is planning to bring its interleukin-2-targeting drug candidate [...]
Scientists aren’t entirely sure what causes rosacea, or why it [...]
Sanofi is back with its second pact of the day, [...]